期刊文献+

中晚期宫颈鳞癌放化疗后复发未控相关因素分析 被引量:6

Analysis of Clinical and Pathological Factors of Persistent or Recurrent Medium-term and Advanced Cervical Squamous Carcinoma
下载PDF
导出
摘要 目的:探讨中晚期宫颈鳞癌放化疗后复发未控的相关因素,以提高宫颈鳞癌放化疗的疗效。方法:对我院2007年1月至2009年12月收治的166例中晚期宫颈鳞癌进行回顾性分析,其中复发未控38例(复发未控组),无复发未控128例(无复发未控组),比较两组的临床分期、组织学分级、肿瘤大小、淋巴结转移、治疗前Hb水平、放疗剂量、化疗疗程及放疗时间,分析其与复发未控的关系。结果:复发未控组组织学分级低分化、宫颈局部癌组织≥4cm、有淋巴结转移、治疗前Hb水平低所占比例与无复发未控组比较,差异均有统计学意义(P<0.05)。复发未控组化疗疗程>3、放疗时间超过8周所占比例与无复发未控组比较,差异均有统计学意义(P<0.05);而放疗剂量与复发未控无明显的相关性。结论:肿瘤分化程度低、宫颈局部癌组织大、有淋巴结转移、治疗前Hb水平低的宫颈鳞癌患者放化疗后易发生复发未控,而化疗疗程及放疗时间也是影响中晚期宫颈鳞癌放化疗后复发未控的因素。 Objective: To explore the relevant factors of persistent or recurrent medium-term and advanced cervical squamous carcinoma for improving the therapeutic efficacy of radiation and chemotherapy. Methods :The clinical data of 166 cases of persistent or recurrent medium-term and advanced cervical squamous carcinoma were retrospectively studied in Changzhou Tumor hospital between January,2007 and December,2009. The 166 patients were divided into two groups :38 cases were in persistent or recurrent group, 128 cases were no persistent or recurrent group, the clinical stage, tumor differenitiation, tumor size, lymph node metastasis,the hemoglobin level before treatment, radiotherapy dose,cycles of chemotherapy and ra- diotherapy treatment between the two groups were compared. And the relationship between these factors and persistence or recurrence of cervical squamous carcinoma were also analyzed. Results:There were significant differences in tumor differentiation, tumor size, lymph node metastasis, the hemoglobin level before treatment between the two groups ( P 〈 0.05). Patients with chemotherapy less than three cycle, radiotherapy treatment time beyond eight weeks were related to persistence or recurrence of cervical squamous carcinoma (P 〈0.05) ,and radiotherapy dose had no relationship with persistence or recurrence of cervical squamous carcinoma. Conclusions: Low tumor differentiation,tumor size more than 4 cm, lymph node metastasis and low level hemoglobin before treatment are the relevant factors of persistent or recurrent mediumterm and advanced cervical squamous carcinoma,cycles of chemotherapy and radiotherapy treatment time can also influent the persistent or recurrent mediumterm and advanced cervical carcinoma greatly.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2012年第10期845-848,共4页 Journal of Practical Obstetrics and Gynecology
关键词 宫颈鳞癌 相关因素 放化疗 复发未控 Cervical squamous carcinoma Relevant factor Radiochemotherapy Persistence and recurrence
  • 相关文献

参考文献8

二级参考文献58

共引文献62

同被引文献45

  • 1陈明晖,巫岳鹏,何科.NAIC联合手术与NAIC和术前放疗联合手术两种方案治疗Ib~IIIb期宫颈癌的临床研究[J].中国妇幼保健,2006,21(5):613-616. 被引量:6
  • 2李利波.三阶梯法在妇女宫颈癌筛查中的价值[J].国际医药卫生导报,2006,12(24):20-21. 被引量:5
  • 3M.Peirettia,I.Zapardielb,Correspondin.Management of recurrent cervical cancer:A review of the literature《SURG ONCOL》2012,2,21.
  • 4朴金霞,徐娜,浦建文.多西紫杉醇联合顺铂治疗宫颈癌放疗后复发的临床研究[J].中国妇幼保健,2007,22(33):4682-4683. 被引量:5
  • 5Wallach JB, Rosenstein MM, Kalnicki S. Localized synchronous squamous cell carcinomas of the esophagus and hypopharynx treated with definitive concurrent chemomdiotherapy with a unified radiother- apy plan. Curr Oncol, 2014,21 (2) :354 -557.
  • 6Ahn D, Kim JH, Sohn JH, et al. Laryngeal preservation in stage Ill/ IV resectable laryngo - hypopharyngeal squamous cell carcinoma fol- lowing concurrent chemoradiotherapy with capecitabine/cisplatin. Mol Clin 0ncol,2013,1 (4) :685 -691.
  • 7Huang Z,Mayr NA,Gao M,et al.Onset time of tumor repopulation for cervical cancer:First evidence from clinical data.International Journal of Radiation Oncology,Biology,Physics,2012,84(2):478-484.
  • 8Bose MV,Gopal G,Selvaluxmy G,et al.Dominant negative Ubiquitin-conjugating enzyme E2C sensitizes cervical cancer cells to radiation.International Journal of Radiation Biology,2012,88(9):629-634.
  • 9Munoz N,Bosch FX,Sanjose S.Epid emiologic classification of human papillomavirus types as sociated with cervical cancer.New England Journal of Medicine,2003,348(6):518-527.
  • 10Zhao Q, Duan R, Yuan J, et al. A reusable localized surface plasmon resonance bioscnsor for quantitative detection of serum squamous cell carcinoma antigen in cervical cancer patients based on silver nanoparticles anay[J].lnt J Nanomcdicine, 2014, 9: 1097-1 t 04. DOI: 10.2147/IJN.$58499.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部